ORANGE COUNTY, Calif. (December 18, 2008) – Beckman Coulter announces U.S. Food and Drug Administration approval for the Access® Soluble Transferrin Receptor (sTfR) Assay and the sTfR/log ferritin index (sTfR Index) as an aid in the diagnosis of iron deficiency anemia (IDA) and the differential diagnosis of IDA and anemia of chronic disease (ACD). The automated sTfR assay used in combination with the sTfR Index, which is calculated on-board Beckman Coulter’s Access and UniCel® DxI® instruments, produces a recommended cutoff that can indicate the nature of a patient’s anemia. The cutoff can assist a physician in determining the best course of treatment, especially for the chronically ill.
